Stock Performance Overview
On 5 December 2025, National Peroxide’s stock closed with a decline of 0.81%, contrasting with the Sensex’s positive movement of 0.36% on the same day. Over the past week, the stock recorded a fall of 4.58%, while the Sensex showed a marginal dip of 0.16%. The one-month performance reveals a sharper decline of 15.43%, whereas the benchmark index advanced by 2.53%. Extending the horizon, the three-month period saw National Peroxide’s shares fall by 18.96%, in contrast to the Sensex’s gain of 6.02%.
Year-on-year, the stock’s performance has been notably subdued, with a decline of 41.86%, while the Sensex posted a 4.66% rise. Year-to-date figures show a 37.50% reduction in the stock’s value, compared to the Sensex’s 9.51% increase. Over three and five years, National Peroxide’s stock has remained flat, with no recorded gains, whereas the Sensex has appreciated by 36.19% and 89.83% respectively. The ten-year comparison further highlights the stock’s stagnation, with zero growth against the Sensex’s substantial 233.77% rise.
Technical Indicators and Market Positioning
National Peroxide is currently trading below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages. This positioning indicates a persistent downward trend without signs of immediate recovery. Despite a slight gain following two consecutive days of decline, the stock remains under pressure relative to its historical trading levels.
Built for the long haul! Consecutive quarters of strong growth landed this Small Cap from Chemicals on our Reliable Performers list. Sustainable gains are clearly ahead!
- - Long-term growth stock
- - Multi-quarter performance
- - Sustainable gains ahead
Financial Health and Profitability Metrics
National Peroxide’s long-term financial indicators reveal significant pressures. The company’s operating profits have shown a compound annual growth rate (CAGR) of -135.58% over the last five years, signalling a contraction in core earnings capacity. The ability to service debt is limited, with an average EBIT to interest ratio of 0.14, indicating that earnings before interest and tax cover interest expenses by a narrow margin.
Return on equity (ROE) averages at 1.90%, reflecting modest profitability relative to shareholders’ funds. The latest six-month period shows a profit after tax (PAT) of ₹1.28 crore, which has declined by 77.78% compared to the previous corresponding period. Additionally, non-operating income for the quarter accounts for 263.49% of profit before tax (PBT), highlighting a reliance on income sources outside the company’s primary operations.
Valuation and Risk Considerations
The stock is considered risky relative to its historical valuation benchmarks. Over the past year, while the stock’s price has fallen by 41.86%, the company’s profits have contracted by 113%. This disparity emphasises the challenges in translating operational results into shareholder returns. The stock’s performance has lagged behind the broader BSE500 index over one year, three months, and three years, indicating underperformance across multiple timeframes.
Shareholding and Sector Context
Promoters remain the majority shareholders of National Peroxide, maintaining significant control over the company’s strategic direction. Operating within the commodity chemicals sector, the company faces sector-specific pressures that have contributed to its current valuation and performance levels.
Is National Peroxide your best bet? SwitchER suggests better alternatives across peers, market caps, and sectors. Discover stocks that could deliver more for your portfolio!
- - Better alternatives suggested
- - Cross-sector comparison
- - Portfolio optimization tool
Summary of Current Situation
National Peroxide’s stock has reached historic lows amid a backdrop of subdued financial performance and limited profitability. The company’s trading below all major moving averages and its financial indicators point to constrained earnings growth and challenges in debt servicing. The stock’s returns have lagged significantly behind benchmark indices over multiple periods, reflecting a prolonged period of underperformance.
While the stock has shown a minor rebound after consecutive declines, the overall trend remains subdued. Investors and market participants will note the company’s reliance on non-operating income to support profitability in recent quarters, alongside a flat trajectory in long-term returns.
Get 1 year of Weekly Picks FREE when you subscribe to MojoOne. Offer ends soon. Start Saving Now →
